Aledade

Health Tech & Medtech · Bethesda, United States · Founded 2014

Provides everything the doctors to create and run an Accountable Care Organization

Valuation $2.5–5B

Revenue $500M–1B

Headcount 1–2k

Unlock exact values

Power Law Unicorn$1–10B valuation tier Thoroughbred$100M+ revenue

Investors

15 investors on Aledade's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage

Echo Health Ventures

Venrock

Mosaic Health Solutions

Series B+ 12 investors entered at this stage

Fidelity Investments

California Medical Association

Tiger Global

IVP

Biomatics Capital Partners

Avidity Partners

Lightspeed Venture Partners

OMERS Growth Equity

OMERS Private Equity

CVF Capital Partners

Meritech Capital

ARCH Venture Partners

Ownership

Who owns Aledade

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.

18.5% Venrock

Venrock 18.5%

Some investors are hidden on this public profile. See the full cap table on Dealroom →

Global footprint

Where Aledade has talent and traffic

Workforce by country

4 countries with
team presence

🇺🇸 United States99.7%

🇯🇵 Japan0.1%

🇵🇦 Panama0.1%

🇨🇳 China0.1%

4 countries shown

Web traffic by country

130K monthly visits
across markets

🇺🇸 United States94.2%

🇬🇧 United Kingdom0.7%

🇳🇬 Nigeria0.7%

🇮🇳 India0.7%

🇮🇩 Indonesia0.6%

Top 5 markets shown

Talent graph

The shape of Aledade's talent

Dealroom maps Aledade's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

15 standout operatorsDealroom-flagged across the org

17 AI specialistsincl. 6 core researchers

1,927 employees mappedperson by person

DimensionScore

AI Talentlive

Engineering

Product

Go-to-market

Leadership

Research

Book a demo to unlock Aledade's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$4k patent portfolio · 1 active families

Estimated portfolio value

$4k

<0.01% of valuation · 100.9× smaller than top peer MediTrust Health ($383k)

1 active patent families

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Aledade's 3 investments and acquisitions.

Every disclosed deal where Aledade appeared as a backer or acquirer, 2022–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Aledade's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount

By stageCount

By periodCount

02 · Portfolio market map

Aledade's portfolio, mapped.

Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

Stage

Period

3 of 3 deals

Market sentiment

What the market is saying about Aledade

An AI-synthesized read of the highest-engagement posts about Aledade on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Aledade on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles